Related Experiment Video
Updated: Jul 16, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and
Jianyong Liu1, Heather Martin, Meir Shamay
1Johns Hopkins University School of Medicine, Bunting-Blaustein Building CRB308, 1650 Orleans Street, Baltimore, MD 21231, USA.
Abstract:
The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen (LANA) protein interacts with glycogen synthase kinase 3 (GSK-3) and relocalizes GSK-3 in a manner that leads to stabilization of beta-catenin and upregulation of beta-catenin-responsive cell genes. The LANA-GSK-3 interaction was further examined to determine whether there were additional downstream consequences. In the present study, the nuclear GSK-3 bound to LANA in transfected cells and in BCBL1 primary effusion lymphoma cells was found to be enriched for the inactive serine 9-phosphorylated form of GSK-3. The mechanism of inactivation of nuclear GSK-3 involved LANA recruitment of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) and the ribosomal S6 kinase 1 (RSK1). ERK1/2 and RSK1 coprecipitated with LANA, and LANA was a substrate for ERK1 in vitro. A model is proposed for the overall inactivation of nuclear GSK-3 that incorporates the previously described GSK-3 phosphorylation of LANA itself. Functional inactivation of nuclear GSK-3 was demonstrated by the ability of LANA to limit phosphorylation of the known GSK-3 substrates C/EBPbeta and C/EBPalpha. The effect of LANA-mediated ablation of C/EBP phosphorylation on differentiation was modeled in the well-characterized 3T3L1 adipogenesis system. LANA-expressing 3T3L1 cells were impaired in their ability to undergo differentiation and adipogenesis. C/EBPbeta induction followed the same time course as that seen in vector-transduced cells, but there was delayed and reduced induction of C/EBPbeta transcriptional targets in LANA-expressing cells. We conclude that LANA inactivates nuclear GSK-3 and modifies the function of proteins that are GSK-3 substrates. In the case of C/EBPs, this translates into LANA-mediated inhibition of differentiation.
Insights
Kaposi's sarcoma-associated herpesvirus LANA protein inactivates nuclear GSK-3 by recruiting ERK1/2 and RSK1. This LANA-mediated GSK-3 inactivation inhibits C/EBP phosphorylation, impairing cell differentiation.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) interacts with glycogen synthase kinase 3 (GSK-3).
- This interaction leads to beta-catenin stabilization and upregulation of beta-catenin-responsive genes.
Purpose of the Study:
- To investigate the downstream consequences of the LANA-GSK-3 interaction.
- To elucidate the mechanism by which LANA affects nuclear GSK-3 activity and its substrates.
Main Methods:
- Co-immunoprecipitation assays to detect protein interactions.
- In vitro kinase assays to assess LANA as a substrate.
- Analysis of GSK-3 substrate phosphorylation in LANA-expressing cells.
- Modeling differentiation in 3T3L1 adipogenesis system.
Main Results:
- Nuclear GSK-3 bound to LANA is enriched in its inactive, serine 9-phosphorylated form.
- LANA recruits extracellular signal-regulated kinases 1 and 2 (ERK1/2) and ribosomal S6 kinase 1 (RSK1) for GSK-3 inactivation.
- LANA expression impairs the phosphorylation of GSK-3 substrates C/EBPbeta and C/EBPalpha.
- LANA-expressing 3T3L1 cells show impaired adipogenesis and delayed/reduced induction of C/EBPbeta targets.
Conclusions:
- LANA inactivates nuclear GSK-3 through recruitment of ERK1/2 and RSK1.
- This inactivation modifies the function of GSK-3 substrates, including C/EBPs.
- LANA-mediated inhibition of C/EBP phosphorylation results in impaired cell differentiation.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

